Pyrimethamine-sulfadoxine Treatment of Congenital Toxoplasmosis: Follow-up of 78 Cases Between 1980 and 1997
- 1 January 1998
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 30 (3), 295-300
- https://doi.org/10.1080/00365549850160963
Abstract
The purpose of this study was to determine the clinical and immunological outcome of 78 children with congenital toxoplasmosis treated with the pyrimethamine-sulfadoxine combination between 1980 and 1997. Children were divided into 3 groups according to the initial duration of treatment (always including folinic acid, 5 mg/week by mouth), as follows: pyrimethamine (1.25 mg/kg every 15 d) + sulfadoxine (25 mg/kg every 15 d) for 12 months (Group 1, 47 children), or for 24 months, with or without prenatal therapy (respectively, Group 2, 19 children, and Group 3, 12 children). Chorioretinitis occurred in 23% of these 78 children. Four children had unilateral blindness, 1 had mild epileptic fits and 1 had psychomotor retardation. The lowest rate of sequelae were in Groups 2 and 3. Immunological rebounds, generally without clinical repercussions, occurred frequently (90% of cases on average) during, or more often after therapy, regardless of the treatment duration. Treatment was always well tolerated. Our current treatment strategy for congenital toxoplasmosis consists of a 24-month course of pyrimethamine-sulfadoxine (Fansidar) combined with folinic acid (Lederfoline). If the prenatal diagnosis is positive, we also prescribe this treatment to the mother until delivery. This combination offers satisfactory compliance, adequate serum concentrations, and good preventive efficacy.Keywords
This publication has 13 references indexed in Scilit:
- Prenatal diagnosis of congenital toxoplasmosis in 261 pregnanciesPrenatal Diagnosis, 1997
- Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgGThe Pediatric Infectious Disease Journal, 1995
- Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii InfectionNew England Journal of Medicine, 1994
- Congenital Infection With Toxoplasma gondiiPediatric Annals, 1994
- Early and Longitudinal Evaluations of Treated Infants and Children and Untreated Historical Patients with Congenital Toxoplasmosis: The Chicago Collaborative Treatment TrialClinical Infectious Diseases, 1994
- Toxoplasmose congénitale. Prise en charge et devenirMedecine Et Maladies Infectieuses, 1993
- Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study GroupAntimicrobial Agents and Chemotherapy, 1992
- Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatmentThe Journal of Pediatrics, 1989
- RESULTS OF 20-YEAR FOLLOW-UP OF CONGENITAL TOXOPLASMOSISThe Lancet, 1986
- Congenital ToxoplasmosisNew England Journal of Medicine, 1974